Nasdaq
$0.9861▲ 2.72%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.1MShares out 3.1M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
33- 10.13After-hours26.10.14 06:334Ownership#●●●
Cadrenal Therapeutics, Inc.
Insider Pham Quang X of Cadrenal Therapeutics, Inc. filed a Form 4 statement of changes in beneficial ownership of securities on October 9, 2026. This filing officially records the changes in the insider's equity holdings.…more
$0.9861+2.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13After-hours26.10.14 06:334Ownership
Cadrenal Therapeutics, Inc.
Insider Golden Lee Scott of Cadrenal Therapeutics, Inc. reported a change in beneficial ownership of securities as of October 9, 2026. This filing provides the details of the insider's equity position change via Form 4.…more
$0.9861+2.72%vs prev closeView filingShare - 10.13After-hours26.10.14 06:324Ownership
Cadrenal Therapeutics, Inc.
Insider John Raymond Murphy of Cadrenal Therapeutics, Inc. reported a change in beneficial ownership of securities as of October 9, 2026. This filing formalizes the insider's equity transaction via Form 4.…more
$0.9861+2.72%vs prev closeView filingShare
32 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.7Pre-market26.10.07 20:00#●●●#●●●#●●●
Cadrenal Therapeutics Initiates Strategic Review to Explore Sale and Partnerships…more
Cadrenal Therapeutics has retained Tungsten Advisors to explore strategic alternatives, including potential asset sales or corporate partnerships, to maximize shareholder value. The company noted that there is no guarantee this process will lead to a specific transaction.…more
$0.9861+2.72%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.21After-hours26.09.22 05:30
●●●●●●●● ●●●●● ●●●●●●
Cadrenal Therapeutics announced its participation in the upcoming Lytham Partners Fall 2026 Investor Conference for webcasts and one-on-one meetings. This is a standard investor relations activity and does not provide immediate material impact on the stock price.…more
$0.9861+2.72%vs prev close - 9.3Pre-market26.09.03 21:00
●●●●●●●● ●●●●● ●●●●●●
Cadrenal Therapeutics will participate in the H.C. Wainwright Global Investment Conference to discuss its clinical pipeline and strategic partnering process. Management will present updates and engage in one-on-one meetings with investors.…more
$0.9861+2.72%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report